Syndax Pharmaceutica
SNDX
Delayed Nasdaq - 10/15 10:00:00 pm
6.6USD
+3.29%
Upcoming events on SYNDAX PHARMACEUTICALS INC
11/07/18 Q3 2018 Earnings Release (Projected)
02/28/19 FY 2018 Earnings Release (Projected)
05/06/19 Q1 2019 Earnings Release (Projected)
08/05/19 Interim 2019 Earnings Release (Projected)
Past events on SYNDAX PHARMACEUTICALS INC
10/03/18 | 03:10pmCantor Global Healthcare Conference
09/24/18 | 07:30pmInternational Association for the Study of Lung Cancer Conference
09/14/18 | 06:15pmMorgan Stanley Global Health Care Conference
09/05/18Citi Biotech Conference
Upcoming sector events for SYNDAX PHARMACEUTICALS INC
10/16/18 | 12:45pm JOHNSON & JOHNSON : Q3 2018 Earnings Release
10/16/18 | 02:30pm JOHNSON & JOHNSON : Q3 2018 Earnings Call
10/16/18 | 10:00am MERCK KGAA : Capital Markets Day
10/17/18 | 02:00pm ROCHE HOLDING LTD. (BEARER SHARE) : Q3 2018 Sales and Revenue Call
Past sector events for SYNDAX PHARMACEUTICALS INC
10/13/18 | 03:30pmCANOPY GROWTH CORP : TheStreet Boot Camp for Investors Conference
10/12/18 | 12:15pmBIOGEN INC : European Committee for Treatment and Research Congress - Poster P1201
10/12/18 | 12:15pmMERCK KGAA : European committee for treatment and research in multiple sclerosis congress - abstract no: 0950-002
10/12/18 | 01:27amALLERGAN PLC : American Society For Dermatologic Surgery Meeting - Abstract OA145
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
2,11
2,19
-3,7%

1,58
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-61,9
-62,5
0,92%

-78,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-62,0
-61,2
-1,2%

-78,5
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-60,8
-60,0
-1,4%

-77,7
Net income
Million $
Released
Forecast
Spread
-60,8
-60,0
-1,4%

-76,7
EPS
 $
Released
Forecast
Spread
-2,90
-2,88
-0,69%

-3,15
Announcement Date03/05/2018
Quarterly / Semiannualy publications
Quarterly resultsQ2
2018
Q3
2018 (e)
Sales
Million $
Released
Forecast
Spread
0,38
0,31
22%

0,37
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-19,0
-21,2
11%

-19,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-18,4
-21,0
12%

-18,9
Net income
Million $
Released
Forecast
Spread
-18,4
-20,9
12%

-18,9
EPS
 $
Released
Forecast
Spread
-0,74
-0,87
15%

-0,79
Announcement Date08/07/2018